🔗 Share this article

Chancellor Reeves has revealed she is planning "focused steps to deal with household expense issues" in the upcoming Budget.

Speaking to media outlets, she noted that reducing price rises is a shared responsibility of both the government and the Bank of England.

The UK's price growth is projected to be the most elevated among the Group of Seven developed nations this year and the following year.

Potential Utility Bill Measures

Sources suggest the administration could take action to bring down energy bills, for instance by cutting the present 5% level of value-added tax applied on energy.

A further approach is to reduce some of the policy costs presently included in bills.

Budgetary Constraints and Expert Expectations

The administration will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these actions.

The view from most analysts is that the Chancellor will have to announce tax rises or budget cuts in order to fulfill her self-imposed debt limits.

Earlier on the same day, analysis indicated there was a £22 billion gap for the Treasury chief to fill, which is at the more modest range of projections.

"It is a collective job between the central bank and the government to continue tackling some of the drivers of inflation," Reeves told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the chancellor said the latest figures from the OBR had not altered her commitment to manifesto promises not to increase tax levels on income tax, VAT or social security contributions.

She attributed an "uncertain world" with rising international and commercial tensions for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

International Trade Disputes

Addressing concerns about the UK's economic relations with the Asian nation she said: "The UK's security interests invariably take priority."

Recent statement by Chinese authorities to tighten export controls on critical minerals and other materials that are key for advanced tech production led American leader the US President to threaten an extra 100% import tax on imports from China, increasing the possibility of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary called the Chinese decision "economic coercion" and "a global supply chain control attempt."

Questioned on considering the US offer to join its conflict with the Asian nation, Reeves said she was "deeply worried" by China's measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "bad for the world economy and causes further obstacles."

"I believe there are areas where we should confront China, but there are also significant opportunities to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The Treasury chief also affirmed she was cooperating with other major economies "regarding our own critical minerals approach, so that we are reduced dependence."

Health Service Drug Costs and Investment

The Chancellor also recognized that the cost the National Health Service pays for drugs could go up as a result of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the biggest global drug companies have said in recent statements that they are either halting or canceling projects in the United Kingdom, with several attributing the low prices they are obtaining.

Recently, the Science Minister said the price the NHS pays for drugs would need to increase to halt businesses and pharmaceutical investment departing from the United Kingdom.

Reeves told media: "It has been observed because of the payment system, that medical research, innovative medicines have not been available in the UK in the extent that they are in other EU nations."

"The objective is to make sure that individuals receiving treatment from the NHS are can receive the finest critical drugs in the globe. And so we are examining all of that, and... aiming to obtain more investment into Britain."